|
Guest
|
Most recent articles on breast cancer and metastasis:
Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with
poor prognosis in early-stage breast cancer.
Buess M, Rajski M, Vogel-Durrer BM, Herrmann R, Rochlitz C.
Neoplasia. 2009 Oct;11(10):987-1002.
8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein
underexpressed in invasive breast carcinoma of poor prognosis.
Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, Cazaubon S, Gruel N,
Colasson H, Nicolas A, Chaverot N, Molinié V, Reyal F, Sigal-Zafrani
B, Terris B, Delattre O, Radvanyi F, Perez F, Vincent-Salomon A,
Nahmias C.
PLoS One. 2009 Oct 1;4(10):e7239.
Tumor microenvironment of metastasis (TMEM): a novel tissue-based
assay for metastatic risk in breast cancer.
Robinson BD, Jones JG.
Future Oncol. 2009 Sep;5(7):919-21.
Vorinostat inhibits brain metastatic colonization in a model of triple-
negative breast cancer and induces DNA double-strand breaks.
Palmieri D, Lockman PR, Thomas FC, Hua E, Herring J, Hargrave E,
Johnson M, Flores N, Qian Y, Vega-Valle E, Taskar KS, Rudraraju V,
Mittapalli RK, Gaasch JA, Bohn KA, Thorsheim HR, Liewehr DJ, Davis S,
Reilly JF, Walker R, Bronder JL, Feigenbaum L, Steinberg SM,
Camphausen K, Meltzer PS, Richon VM, Smith QR, Steeg PS.
Clin Cancer Res. 2009 Oct 1;15(19):6148-57.
Bone morphogenetic proteins in development and progression of breast
cancer and therapeutic potential (review).
Ye L, Bokobza SM, Jiang WG.
Int J Mol Med. 2009 Nov;24(5):591-7.
InTextoResearch, Baelen, Liège, Wallonie (Wallonia), Belgique
(Belgium) & Agence Wallonne d’Information Scientifique (AWIS) (Marc
Lacroix, scimedweb at (no spam) mail.com) |
|
|
